BRE is an antiapoptotic protein in vivo and overexpressed in human hepatocellular carcinoma
Bianca Chan(Chinese University of Hong Kong), S. Chen(Chinese University of Hong Kong), Ka‐Fai To(Chinese University of Hong Kong), KK Lee(Chungbuk National University), Joseph C.K. Leung, Arthur K. Ching(Chinese University of Hong Kong), Quan Li(Nanchang University), Nelson L.S. Tang(Chinese University of Hong Kong), J Y-H Chan(The University of Texas MD Anderson Cancer Center), K.N. Lai(Queen Mary Hospital), Anthony E. James(Chinese University of Hong Kong), P-C Shaw(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong), P-L Lim(Chinese University of Hong Kong)
Cited by 46
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Histone H3 Methylation by Set2 Directs Deacetylation of Coding Regions by Rpd3S to Suppress Spurious Intragenic Transcription
|Cell|2005|1.3k
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895